4 insiders reported 39 Form 4 transactions for Terns Pharmaceuticals, Inc. (TERN) over the past 18 months (most recent 2026-05-05). Recent activity: Gengos Andrew (Chief Financial Officer) Sell 40,503 shares, Burroughs Amy L. (Chief Executive Officer) Sell 146,614 shares, Kuriakose Emil (Chief Medical Officer) Sell 24,562 shares, Gengos Andrew (Chief Financial Officer) Sell 68,750 shares, Burroughs Amy L. (Chief Executive Officer) Sell 8,319 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-05 | Gengos Andrew | Chief Financial Officer | Sell | 40,503 | $2.1M |
| 2026-05-05 | Burroughs Amy L. | Chief Executive Officer | Sell | 146,614 | $7.8M |
| 2026-05-05 | Kuriakose Emil | Chief Medical Officer | Sell | 24,562 | $1.3M |
| 2026-05-05 | Gengos Andrew | Chief Financial Officer | Sell | 68,750 | $3.6M |
| 2026-05-05 | Burroughs Amy L. | Chief Executive Officer | Sell | 8,319 | $440,907 |
| 2026-05-05 | Kuriakose Emil | Chief Medical Officer | Sell | 81,953 | $4.3M |
| 2026-05-05 | Burroughs Amy L. | Chief Executive Officer | Sell | 150,000 | $8.0M |
| 2026-04-02 | Kuriakose Emil | Chief Medical Officer | Sell | 942 | $49,693 |
| 2026-03-17 | Burroughs Amy L. | Chief Executive Officer | Buy | 14,583 | $67,665 |
| 2026-03-17 | Burroughs Amy L. | Chief Executive Officer | Sell | 11,813 | $550,131 |
| 2026-03-17 | Burroughs Amy L. | Chief Executive Officer | Sell | 2,770 | $131,021 |
| 2026-02-18 | Burroughs Amy L. | Chief Executive Officer | Buy | 14,583 | $67,665 |
| 2026-02-18 | Burroughs Amy L. | Chief Executive Officer | Sell | 2,341 | $89,122 |
| 2026-02-18 | Burroughs Amy L. | Chief Executive Officer | Sell | 8,159 | $319,996 |
| 2026-02-18 | Burroughs Amy L. | Chief Executive Officer | Sell | 4,083 | $162,503 |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Buy | 150,000 | $0 |
| 2026-01-16 | Gengos Andrew | Chief Financial Officer | Buy | 68,750 | $0 |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Buy | 27,083 | $125,665 |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Buy | 27,083 | $125,665 |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Buy | 14,583 | $67,665 |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Sell | 61,228 | $2.3M |
| 2026-01-16 | Burroughs Amy L. | Chief Executive Officer | Sell | 7,521 | $282,263 |
| 2026-01-16 | Kuriakose Emil | Chief Medical Officer | Buy | 56,250 | $0 |
| 2026-01-06 | Burroughs Amy L. | Chief Executive Officer | Buy | 21,551 | $99,997 |
| 2026-01-06 | Burroughs Amy L. | Chief Executive Officer | Buy | 150,000 | $0 |
Source: SEC Form 4 filings · as of 2026-05-05